Page 10 Advertisements Column 4

Manawatu Standard, Volume XLIII, Issue 430, 22 June 1922, Page 10

TUBERCULOSIS CURE

COMMONWEALTH'S INQUIRY. VACCINATION AGAINST TUBERCULOSIS A POSSIBILITY. LONDON, May 23. Tin' visit 10 Australia House of the eminent Swi.-s biologist, M. Spahlinger, who it is hoped has made the greatest discovery of the century with his treatment for the prevention and cure of tuberculous, brings. 10 lij In tho fact that for sovoral months llie Australian Government ha- hooii investigating the new cure. Recently Dr. Nloiri.s and Dr. Isaac Jones (an Australian doctor, who i.- one of the leading biological chemists of England) officially visited Al. Spahlinger's laboratories iii Geneva and reported to the Commonwealth Government, which is now understood to bo thoroughly investigating the process with the view of securing tho rights tor use of the scrum in Australia, M. Spahlinger, in a discussion with a representative of the Sun, mado it clear that his laboratory was working to full capacity, but was unable to supply vaccine or serum until the establishment was enlarged. Do most strongly emphasised that he was unable to treat: individuals. SMALLNESS OF SUPPLY MAKES CONCESSION VALUABLE. 11. Spahlinger is anxious not to raise false hopes, and points out that it is i'utilo for sufferers to write even to Europe for treatment, As a matter of fact, if the present negotiations are successful, patients will actually have' in Australia an earlier opportunity of securing treatment than anywhere else in the world, because the Australian authorities were the first to recognise the importance of the cure, this resulting in .U. Spahlinger giving the Commonwealth tho lirst option, though several other countries are now endeavouring to secure supplies of serum. The value of the concession is evident from the fact thai if Australia receives suppile- other countries cannot, because the amouni el vaccine and .scrum that can be produced is limited by M. Spahlinger's personal capacity and by liuancial considerations. One leaves Al. Spahlinger with four (ho his uppermost m one's mjnd: Of his you'.iiful appearance (lie is only 28 years of age); of hi- not being a doctor, but a scientist; of hi.; modest hope that no one will accept his process without thoroughly invo-th.aiing it; and of the extraordinary po.--ibility of Australians being vaccinated against tuberculosis by a similar method tu that for smallpox. M. Spahiinger is a native of Switzerland, and has been carrying out experiments in Geneva, where leading British specialists visited him in 1921. The central idea of his treatment is the mixture of a number of anti-toxins (or serum.-) prepared from several animals. It is claimed that the combination of several vaccines has affected cure-. The serum takes about four years to prepare, and a very small amount of it is available. At. Spahlinger was present at the AntiTuberculosis Conference held in London hist July, but was, not invited to expound his views.

SPAIILIXGER'S PROCESS. PROBABLE FREE SUPPLY FOR THE POOR. LONDON, June 3. M Spahlinger. the discoverer of the new n.nti-iuberculosis vaccine, returns to Geneva 10-morrow. It is understood that Japan is inquiring as 10 supplies for the East, but it is believed thai Australia could have ilie right of being a manufacturing and disiribuiing centre for the Far East. M. Spahlinger who, according to his friends, soeiii £BO.OOO of Ids patrimony in perfecting ln\ process, saw- that the production of the vaccine serum" is a tliflii tilt and long process. It has taken 14 years to mature. "It is essential," he said, "for the next few year?, that 1 should myself produce the vaccine, for I do nor wish someone lo produce ii who is Halle to make a mistake, however slight, and so do considerable damage, and discredit the whole process afterwards. "I am prepared to train an Australian. provided certain conditions are accepted, such as a cheap supply, and possibly a free one for poor persons.'' , . . , It is known that Dr. Morris, principal medical officer, Australia House, strongly recommends the Commonwealth s acceptance of the Spahlinger treatment.

FSAD